StockData
Cytokinetics Inc logo

Cytokinetics Inc (CYTK) stock

CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$51.65−1.52 (-2.86%)

Close on Nov 17, 2026Market cap $7.18BP/E –Yield –

Cytokinetics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Cytokinetics's total debt was $275.56M at Jun 30, 2026. For fiscal 2025 it was $287.57M, up 174.5% from the year before. Over ten years it grew 34.7% a year on average. The highest annual figure on record is $287.57M in fiscal 2025.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$287.57M+174.5%
FY2024Dec 31, 2024$104.75M+53.0%
FY2023Dec 31, 2023$68.46M+5.7%
FY2022Dec 31, 2022$64.77M+36.7%
FY2021Dec 31, 2021$47.37M+2.5%
FY2020Dec 31, 2020$46.21M+2.6%
FY2019Dec 31, 2019$45.05M+6.2%
FY2018Dec 31, 2018$42.41M+33.5%
FY2017Dec 31, 2017$31.78M+6.3%
FY2016Dec 31, 2016$29.88M+104.1%
FY2015Dec 31, 2015$14.64M–
FY2014Dec 31, 2014$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$275.56M+58.9%
Q1 FY2026Mar 31, 2026$292.02M+178.2%
Q4 FY2025Dec 31, 2025$287.57M+174.5%
Q3 FY2025Sep 30, 2025$176.03M+68.4%
Q2 FY2025Jun 30, 2025$173.46M+66.2%
Q1 FY2025Mar 31, 2025$104.99M+53.6%
Q4 FY2024Dec 31, 2024$104.75M+53.0%
Q3 FY2024Sep 30, 2024$104.54M+71.7%
Q2 FY2024Jun 30, 2024$104.35M+67.0%
Q1 FY2024Mar 31, 2024$68.34M+6.6%
Q4 FY2023Dec 31, 2023$68.46M+5.7%
Q3 FY2023Sep 30, 2023$60.89M-4.2%
Q2 FY2023Jun 30, 2023$62.49M+0.2%
Q1 FY2023Mar 31, 2023$64.11M+4.8%
Q4 FY2022Dec 31, 2022$64.77M+36.7%
Q3 FY2022Sep 30, 2022$63.54M+35.0%
Q2 FY2022Jun 30, 2022$62.34M+33.2%
Q1 FY2022Mar 31, 2022$61.17M+31.5%
Q4 FY2021Dec 31, 2021$47.37M+2.5%
Q3 FY2021Sep 30, 2021$47.08M+2.5%
Q2 FY2021Jun 30, 2021$46.79M+2.5%
Q1 FY2021Mar 31, 2021$46.50M+2.6%
Q4 FY2020Dec 31, 2020$46.21M+2.6%
Q3 FY2020Sep 30, 2020$45.92M+2.6%
Q2 FY2020Jun 30, 2020$45.63M+2.6%
Q1 FY2020Mar 31, 2020$45.34M+6.4%
Q4 FY2019Dec 31, 2019$45.05M+6.2%
Q3 FY2019Sep 30, 2019$44.76M+6.8%
Q2 FY2019Jun 30, 2019$44.47M+37.4%
Q1 FY2019Mar 31, 2019$42.59M+33.3%
Q4 FY2018Dec 31, 2018$42.41M+33.5%
Q3 FY2018Sep 30, 2018$41.91M+38.3%
Q2 FY2018Jun 30, 2018$32.37M+7.3%
Q1 FY2018Mar 31, 2018$31.95M+6.4%
Q4 FY2017Dec 31, 2017$31.78M+6.3%
Q3 FY2017Sep 30, 2017$30.30M+1.9%
Q2 FY2017Jun 30, 2017$30.16M–
Q1 FY2017Mar 31, 2017$30.02M–
Q4 FY2016Dec 31, 2016$29.88M–
Q3 FY2016Sep 30, 2016$29.74M–

More Cytokinetics figures

See a number that looks wrong?